Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. innovative formulations, llc
WARNING LETTER
•innovative formulations, llc •February 22, 2024

FDA WARNING_LETTER - innovative formulations, llc - February 22, 2024

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

The FDA issued a Warning Letter to Insane Labz on February 22, 2024, regarding their "WAKE THE DEAD SMELLING SALTS" drug product. The FDA reviewed the firm's website (insanelabz.com) on November 14, 2023, and Amazon storefront on February 14, 2024.

The product is cited as an unapproved new drug and a misbranded drug. It is considered a drug under sections 201(g)(1)(B) and 201(g)(1)(C) of the FD&C Act due to its intended use as a stimulant, affecting body function and intended for disease diagnosis, cure, mitigation, treatment, or prevention. Labeling claims indicate it releases ammonia gas, triggering a strong inhalation reflex, increasing heart rate, blood pressure, and brain activity, and is used for increased focus.

The product, containing ammonium chloride, is deemed an unapproved new drug under section 505(a) and 301(d) of the FD&C Act because it is not generally recognized as safe and effective (GRASE) for its intended use. Specifically, as a reflex stimulant, it falls under section 505G(a)(4) of the FD&C Act, subject to a 2008 proposed rule (73 FR 34895)

Company
innovative formulations, llc
Inspection Date
February 22, 2024
Product Type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Tina Smith (Director)
Open in Dashboard

ID · 40e34864-7b7e-47e6-88b1-7671db550b65

Violation Codes10
21.U.S.C. 355(a)21 U.S.C. 352(ee)21 U.S.C. 331(d)21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(g)(1)(C)21 U.S.C. 321(p)21 U.S.C. 355h(a)(4)21 CFR 201.12821 CFR 33021 U.S.C. 331(a)

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.